In This Article:
Looking at Bristol-Myers Squibb Company's (NYSE:BMY ) insider transactions over the last year, we can see that insiders were net buyers. That is, there were more number of shares purchased by insiders than there were sold.
While insider transactions are not the most important thing when it comes to long-term investing, logic dictates you should pay some attention to whether insiders are buying or selling shares.
See our latest analysis for Bristol-Myers Squibb
The Last 12 Months Of Insider Transactions At Bristol-Myers Squibb
Over the last year, we can see that the biggest insider purchase was by Executive VP Samit Hirawat for US$100k worth of shares, at about US$54.68 per share. That means that an insider was happy to buy shares at around the current price of US$58.76. Of course they may have changed their mind. But this suggests they are optimistic. We do always like to see insider buying, but it is worth noting if those purchases were made at well below today's share price, as the discount to value may have narrowed with the rising price. The good news for Bristol-Myers Squibb share holders is that an insider was buying at near the current price. Samit Hirawat was the only individual insider to buy shares in the last twelve months.
You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!
Bristol-Myers Squibb is not the only stock that insiders are buying. For those who like to find small cap companies at attractive valuations, this free list of growing companies with recent insider purchasing, could be just the ticket.
Insiders At Bristol-Myers Squibb Have Bought Stock Recently
Over the last three months, we've seen significantly more insider buying, than insider selling, at Bristol-Myers Squibb. Executive VP Samit Hirawat spent US$100k on stock. But insider Phil Holzer sold shares worth US$39k. The buying outweighs the selling, which suggests that insiders may believe the company will do well in the future.
Does Bristol-Myers Squibb Boast High Insider Ownership?
Many investors like to check how much of a company is owned by insiders. We usually like to see fairly high levels of insider ownership. Bristol-Myers Squibb insiders own about US$90m worth of shares. That equates to 0.07% of the company. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.